<DOC>
	<DOCNO>NCT01425164</DOCNO>
	<brief_summary>In hemodialysed patient , coronary heart disease lead cause mortality morbidity . Most commonly use drug ischemia use patient , prospective data available . Among anti-ischemic drug betablocker provide evidence beneficial effect outcome , dialysis patient , carvedilol successfully use also heart failure . Ivabradine late anti-ischemic drug provide evidence benefit general population , study available dialysis patient . Aim present study compare randomize , double-blind , parallel group trial effect ivabradine compare carvedilol event-free survival 18 month hemodialysed population patient establish coronary heart disease .</brief_summary>
	<brief_title>Ischemia In Hemodialysed Patients : Ivabradine Versus Carvedilol</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>document CAD evidence either coronary angiography ( &gt; 50 % diameter stenosis major coronary artery ) previously document myocardial infarction transient ischemia evidence abnormality exercise ECG ( standard Bruce protocol ) , myocardial perfusion scintigraphy , stress regional wall motion study do within 6 month study entry unstable angina pectoris myocardial infarction coronary revascularization within 3 month study entry ECG abnormality interfere exercise STsegment interpretation ( eg , STsegment depression &gt; 0.5 mm , QRS duration &gt; 0.1 second , Rwave amplitude &lt; 8 mm , preexcitation , atrial fibrillation ) inability undergo exercise test uncontrolled hypertension serious condition ( medical , psychiatric , cognitive , social ) symptom sufficient severity ( Canadian class II high ) require antianginal medication nitrate heart failure great firstdegree atrioventricular block , asthma , contraindication betablocker therapy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>hemodialysis</keyword>
	<keyword>coronary heart disease</keyword>
	<keyword>angina</keyword>
	<keyword>betablocker</keyword>
	<keyword>carvedilol</keyword>
	<keyword>ivabradine</keyword>
</DOC>